# Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction

> **NCT05593549** · EARLY_PHASE1 · RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes
- Healthy Aging

## Interventions

- **DRUG:** Trehalose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05593549
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05593549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05593549, "Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05593549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*